Member Login

Venture Capital Directory ::  Global Biotechnology Investors Profile

Global Biotechnology Investors Profile

Global Biotechnology Investors Profile
Here are some more biotechnology / healthcare investors profile for members, this week, we pick 3 different institutions from different regions: LSP, BioAdvance and First Floor Capital

Life Science Partners (Europe & US)
LSP is one of the world’s largest specialized healthcare and biotechnology investment firms. With a history going back to the late eighties, LSP has grown into a global firm with offices in Amsterdam, Munich and Boston. The LSP team consists of dedicated investment professionals who seek investments both in Europe and the US across the entire spectrum of private and publicly-traded life science companies.

Sectors: Medical devices, Anti-body, therapeutics, food products

BioAdvance (USA)

Biotechnology Greenhouse Corporation of Southeastern Pennsylvania. Their expertise by focusing on biopharmaceutical opportunities including therapeutics, devices and related technologies. The region enjoys as a base of academic institutions, research facilities, hospitals and other healthcare resources, and it has the second largest concentration of biopharmaceutical jobs in North America.

Sectors: Medical devices, implants, pharmaceuticals, e-health, university sponsored R&D projects

First Floor Capital (Malaysia)
FirstFloor Capital manages both private and institutional funds and has invested in technology companies ranging from Nutraceuticals to Artificial Intelligence and in stages ranging from seed to pre-mezzanine. Malaysian VC firms, FirstFloor Capital is partner run and owned.

Sectors: technology related healthcare opportunities such as E-health, bioinformatics.

The above companies are from our Global Biotechnology Capital Providers Guide, this includes over 900 biotechnology/healthcare related investment firms globally, please check out this guide from our website http://researchwhitepaper.com

Disclosure: These companies are general information only, they do not constitute to any recommendation directly or indirectly.

Back
Copyright © 2012 Research Whitepaper. Powered by Moneycat Consulting | SEO by E-Web Marketing